NM_181332.3:c.897A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_181332.3(NLGN4X):​c.897A>G​(p.Ile299Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,210,157 control chromosomes in the GnomAD database, including 16 homozygotes. There are 371 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0069 ( 8 hom., 171 hem., cov: 23)
Exomes 𝑓: 0.00066 ( 8 hom. 200 hem. )

Consequence

NLGN4X
NM_181332.3 missense

Scores

1
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0510

Publications

2 publications found
Variant links:
Genes affected
NLGN4X (HGNC:14287): (neuroligin 4 X-linked) This gene encodes a member of the type-B carboxylesterase/lipase protein family. The encoded protein belongs to a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. The encoded protein interacts with discs large homolog 4 (DLG4). Mutations in this gene have been associated with autism and Asperger syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
NLGN4X Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • autism, susceptibility to, X-linked 2
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047011375).
BP6
Variant X-5903781-T-C is Benign according to our data. Variant chrX-5903781-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377303.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00687 (769/111906) while in subpopulation AFR AF = 0.0236 (727/30804). AF 95% confidence interval is 0.0222. There are 8 homozygotes in GnomAd4. There are 171 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLGN4XNM_181332.3 linkc.897A>G p.Ile299Met missense_variant Exon 5 of 6 ENST00000381095.8 NP_851849.1 Q8N0W4-1A0A024RBV0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLGN4XENST00000381095.8 linkc.897A>G p.Ile299Met missense_variant Exon 5 of 6 1 NM_181332.3 ENSP00000370485.3 Q8N0W4-1

Frequencies

GnomAD3 genomes
AF:
0.00687
AC:
768
AN:
111853
Hom.:
8
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0236
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00284
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.0000941
Gnomad OTH
AF:
0.00465
GnomAD2 exomes
AF:
0.00180
AC:
331
AN:
183495
AF XY:
0.000927
show subpopulations
Gnomad AFR exome
AF:
0.0231
Gnomad AMR exome
AF:
0.000838
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000366
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000665
AC:
730
AN:
1098251
Hom.:
8
Cov.:
33
AF XY:
0.000550
AC XY:
200
AN XY:
363607
show subpopulations
African (AFR)
AF:
0.0226
AC:
597
AN:
26403
American (AMR)
AF:
0.00119
AC:
42
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.0000739
AC:
4
AN:
54149
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40534
Middle Eastern (MID)
AF:
0.00121
AC:
5
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000178
AC:
15
AN:
842132
Other (OTH)
AF:
0.00145
AC:
67
AN:
46098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
38
77
115
154
192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00687
AC:
769
AN:
111906
Hom.:
8
Cov.:
23
AF XY:
0.00502
AC XY:
171
AN XY:
34096
show subpopulations
African (AFR)
AF:
0.0236
AC:
727
AN:
30804
American (AMR)
AF:
0.00274
AC:
29
AN:
10587
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2638
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3524
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2667
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6125
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.0000941
AC:
5
AN:
53135
Other (OTH)
AF:
0.00460
AC:
7
AN:
1523
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00295
Hom.:
16
Bravo
AF:
0.00744
ESP6500AA
AF:
0.0235
AC:
90
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.00178
AC:
216

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 18, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Inborn genetic diseases Benign:1
Jan 16, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
3.7
DANN
Benign
0.58
DEOGEN2
Benign
0.16
T;T;T;.;T
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.76
.;T;.;T;.
MetaRNN
Benign
0.0047
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.51
N;N;N;.;N
PhyloP100
0.051
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.12
N;.;N;.;N
REVEL
Benign
0.031
Sift
Benign
0.66
T;.;T;.;T
Sift4G
Benign
0.26
T;T;T;.;T
Polyphen
0.0030
B;B;B;B;B
Vest4
0.17
MVP
0.45
MPC
1.1
ClinPred
0.0045
T
GERP RS
-2.2
Varity_R
0.19
gMVP
0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151073358; hg19: chrX-5821822; API